Rydapt 25 mg soft capsules

*
Pharmacy Only: Prescription
  • Company:

    Novartis Ireland Limited
  • Status:

    Updated
  • Legal Category:

    Product subject to medical prescription which may be renewed (B)
  • Active Ingredient(s):

    *Additional information is available within the SPC or upon request to the company

Updated on 03 July 2024

File name

Rydapt_ REG PIL_PF 24-0138_clean_IPHA_July 2024.pdf

Reasons for updating

  • Change to section 6 - manufacturer

Updated on 23 April 2024

File name

Rydapt_ REG PIL_PF 24-0083_clean_IPHA_April 2024.pdf

Reasons for updating

  • Change to section 4 - how to report a side effect

Updated on 23 April 2024

File name

Rydapt_ REG PIL_PF 24-0084_clean_IPHA_April 2024.pdf

Reasons for updating

  • Change to section 4 - how to report a side effect

Updated on 02 October 2023

File name

Rydapt_REG SPC_PF23-0130_June2023_clean_IPHA.pdf

Reasons for updating

  • Change to section 4.8 - Undesirable effects

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 31 July 2023

File name

Rydapt_ REG PIL_PF 23-0130_June2023_clean_IPHA.pdf

Reasons for updating

  • Change to section 4 - possible side effects

Updated on 31 July 2023

File name

Rydapt_REG SPC_PF23-0130_July2023_clean_IPHA.pdf

Reasons for updating

  • Change to section 4.8 - Undesirable effects

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 17 April 2023

File name

Rydapt_REG SPC_PF23-0080_30.03.2023_clean_IPHA.pdf

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 5.2 - Pharmacokinetic properties

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 07 June 2022

File name

Rydapt_REG SPC_PF22-0112_IPHA_May2022.pdf

Reasons for updating

  • Change to section 1 - Name of medicinal product

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 07 June 2022

File name

Rydapt_REG PIL_IPHA_PF22-0112_May2022.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects

Updated on 15 March 2022

File name

Rydapt REG PIL PF22-0063_IPHA_Mar2022.pdf

Reasons for updating

  • Change to section 2 - interactions with other medicines, food or drink

Updated on 11 March 2022

File name

Rydapt_REG SPC_PF22-0063_IPHA_March2022.pdf

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 5.2 - Pharmacokinetic properties

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 19 January 2022

File name

RYDAPT_REGPIL_PF21-0219_August2021_IPHA.pdf

Reasons for updating

  • Previous version of PIL reinstated

Updated on 11 January 2022

File name

Rydapt_REG SPC_PF22-0004_IPHA_Dec2021.pdf

Reasons for updating

  • Change to section 5.1 - Pharmacodynamic properties

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 10 September 2021

File name

RYDAPT REG SPC PF 21-0219 AUG2021clean.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 10 September 2021

File name

RYDAPT_REGPIL_PF21-0219_August2021_IPHA.pdf

Reasons for updating

  • New PIL for new product